It could be a therapeutic target for treating insulin resistance (where the body’s cells become less responsive to insulin) and associated cardiovascular diseases such as metabolic disorders like T2D, obesity, and metabolic syndrome [4,6]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.